Éva Hajós‐Korcsok

1.1k total citations
25 papers, 858 citations indexed

About

Éva Hajós‐Korcsok is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Éva Hajós‐Korcsok has authored 25 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 8 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Éva Hajós‐Korcsok's work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Alzheimer's disease research and treatments (7 papers). Éva Hajós‐Korcsok is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Alzheimer's disease research and treatments (7 papers). Éva Hajós‐Korcsok collaborates with scholars based in United States, United Kingdom and Sweden. Éva Hajós‐Korcsok's co-authors include Trevor Sharp, Mihály Hajós, Sarah F. B. McTavish, László G. Hársing, Sarah E. Gartside, William E. Hoffmann, David Riddell, Kalpana Merchant, Junchong Yu and Tamás Kiss and has published in prestigious journals such as Neuroscience, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Éva Hajós‐Korcsok

25 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éva Hajós‐Korcsok United States	14	520	255	207	165	144	25	858
Laura M. Gault United States	16	431 0.8×	349 1.4×	124 0.6×	180 1.1×	174 1.2×	24	1.0k
Vicky Holland United Kingdom	11	584 1.1×	369 1.4×	156 0.8×	89 0.5×	95 0.7×	13	988
Karla Drescher Germany	17	607 1.2×	488 1.9×	149 0.7×	77 0.5×	166 1.2×	31	1.0k
Valérie Compan France	21	853 1.6×	539 2.1×	210 1.0×	180 1.1×	197 1.4×	39	1.4k
M.B. Hesselink Netherlands	18	665 1.3×	403 1.6×	128 0.6×	135 0.8×	118 0.8×	30	955
Ouissame Mnie‐Filali France	18	747 1.4×	413 1.6×	209 1.0×	86 0.5×	241 1.7×	31	1.1k
Robert A. McArthur Italy	20	538 1.0×	344 1.3×	94 0.5×	201 1.2×	207 1.4×	43	1.2k
Jouni Ihalainen Finland	13	466 0.9×	215 0.8×	223 1.1×	182 1.1×	125 0.9×	24	793
Matthew A. Seager United States	21	696 1.3×	429 1.7×	377 1.8×	141 0.9×	130 0.9×	32	1.1k
Philip Gerrard United Kingdom	17	643 1.2×	418 1.6×	200 1.0×	100 0.6×	134 0.9×	19	1.1k

Countries citing papers authored by Éva Hajós‐Korcsok

Since Specialization

Citations

This map shows the geographic impact of Éva Hajós‐Korcsok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Hajós‐Korcsok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Hajós‐Korcsok more than expected).

Fields of papers citing papers by Éva Hajós‐Korcsok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Hajós‐Korcsok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Hajós‐Korcsok. The network helps show where Éva Hajós‐Korcsok may publish in the future.

Co-authorship network of co-authors of Éva Hajós‐Korcsok

This figure shows the co-authorship network connecting the top 25 collaborators of Éva Hajós‐Korcsok. A scholar is included among the top collaborators of Éva Hajós‐Korcsok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éva Hajós‐Korcsok. Éva Hajós‐Korcsok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dedic, Nina, Lien Wang, Éva Hajós‐Korcsok, et al.. (2024). TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding. Molecular Metabolism. 80. 101883–101883. 11 indexed citations

Dedic, Nina, Philip Jones, Éva Hajós‐Korcsok, et al.. (2023). TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain. CNS Spectrums. 28(2). 259–259. 1 indexed citations

Ahn, Jae Eun, Terence Fullerton, Éva Hajós‐Korcsok, et al.. (2019). Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies. Clinical Pharmacology & Therapeutics. 107(1). 211–220. 24 indexed citations

Qiu, Ruolun, et al.. (2016). P2‐009: PF‐06648671–A Novel Gamma Secretase Modulator: Safety, Tolerability, Pharmacokinetics, and Effects on Plasma Amyloid‐B Levels Following Single Oral Ascending Doses in Healthy Volunteers. Alzheimer s & Dementia. 12(7S_Part_12). 3 indexed citations

Pettersson, Martin, Douglas S. Johnson, John M. Humphrey, et al.. (2014). Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. Bioorganic & Medicinal Chemistry Letters. 25(4). 908–913. 13 indexed citations

Hajós, Mihály, Elena Morozova, Chester J. Siok, et al.. (2013). Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation. Frontiers in Pharmacology. 4. 72–72. 10 indexed citations

Feng, Jianlin, Tamás Kiss, Elie Needle, et al.. (2012). Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice. Neurobiology of Aging. 33(7). 1481.e13–1481.e23. 69 indexed citations

Lu, Yasong, Hugh A. Barton, Louis Leung, et al.. (2012). Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative Analyses. Neurodegenerative Diseases. 12(1). 36–50. 18 indexed citations

Brodney, Michael A., Gabriela Barreiro, Kevin Ogilvie, et al.. (2012). Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors. Journal of Medicinal Chemistry. 55(21). 9224–9239. 44 indexed citations

10.

Hascup, Erin R., Kevin N. Hascup, François Pomerleau, et al.. (2012). An allosteric modulator of metabotropic glutamate receptors (mGluR₂), (+)‐TFMPIP, inhibits restraint stress‐induced phasic glutamate release in rat prefrontal cortex. Journal of Neurochemistry. 122(3). 619–627. 17 indexed citations

11.

Lu, Yasong, David Riddell, Éva Hajós‐Korcsok, et al.. (2012). Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical Analyses. Journal of Pharmacology and Experimental Therapeutics. 342(2). 366–375. 24 indexed citations

12.

Hajós‐Korcsok, Éva, et al.. (2008). P1‐063: Early‐onset noradrenergic loss in Tg2576 mice: Selective vulnerability of hippocampus vs. frontal cortex. Alzheimer s & Dementia. 4(4S_Part_7). 1 indexed citations

13.

Miller, M. W., et al.. (2008). Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation. Schizophrenia Bulletin. 36(2). 410–418. 66 indexed citations

14.

Stephenson, Diane, Andres D. Ramirez, Jill Long, et al.. (2006). Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection. Journal of Neuroscience Methods. 159(2). 291–299. 12 indexed citations

15.

Stephenson, Diane, et al.. (2005). The Effects of a Selective Dopamine D2 Receptor Agonist on Behavioral and Pathological Outcome in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Squirrel Monkeys. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1257–1266. 19 indexed citations

16.

Hajós‐Korcsok, Éva, et al.. (2003). Rapid habituation of hippocampal serotonin and norepinephrine release and anxiety-related behaviors, but not plasma corticosterone levels, to repeated footshock stress in rats. Pharmacology Biochemistry and Behavior. 74(3). 609–616. 66 indexed citations

17.

Hajós, Mihály, et al.. (2002). Norepinephrine but not Serotonin Reuptake Inhibitors Enhance Theta and Gamma Activity of the Septo-Hippocampal System. Neuropsychopharmacology. 28(5). 857–864. 70 indexed citations

18.

Hajós‐Korcsok, Éva & Trevor Sharp. (2002). Electrical stimulation of the dorsal and median raphe nuclei increases extracellular noradrenaline in rat hippocampus: Evidence for a 5-HT-independent mechanism. Pharmacology Biochemistry and Behavior. 71(4). 807–813. 12 indexed citations

19.

Hajós‐Korcsok, Éva, Sarah F. B. McTavish, & Trevor Sharp. (2000). Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. European Journal of Pharmacology. 407(1-2). 101–107. 63 indexed citations

20.

Hajós‐Korcsok, Éva & Trevor Sharp. (1996). 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. European Journal of Pharmacology. 314(3). 285–291. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact